A weekly self-injectable pen called Mounjaro is used to help people lose weight. It contains tirzepatide, an injectable prescription medication used in conjunction with diet and exercise to improve blood sugar (glucose) in individuals with type 2 diabetes mellitus. It helps to lower hunger and avoid cravings by managing blood sugar and energy balance levels.
Its suitability for use in patients with pancreatitis is unknown. is not recommended for usage by those who have type 1 diabetes. Its efficacy and safety in children under the age of eighteen are unknown.
Be the first to review “MOUNJARO”